{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:17:28Z","timestamp":1789395448667,"version":"build-2803163510"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-69885-0","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T23:15:19Z","timestamp":1771629319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Antibody waning and Bordetella pertussis resurgence after the COVID-19 pandemic in the Netherlands"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8809-2241","authenticated-orcid":false,"given":"Channah M.","family":"Gaasbeek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric R. A.","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika M.","family":"van Roon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimphey","family":"van Meijeren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaby","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9902-5790","authenticated-orcid":false,"given":"Marjan","family":"Kuijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5204-2312","authenticated-orcid":false,"given":"Marion","family":"Koopmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hester","family":"de Melker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona R. M.","family":"van der Klis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"van Binnendijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2103-6315","authenticated-orcid":false,"given":"Gerco","family":"den Hartog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"69885_CR1","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.vaccine.2020.12.080","volume":"39","author":"M Middeldorp","year":"2021","unstructured":"Middeldorp, M. et al. Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in the Netherlands in the period March-September 2020. Vaccine 39, 1039\u20131043 (2021).","journal-title":"Vaccine"},{"key":"69885_CR2","doi-asserted-by":"publisher","unstructured":"van Roon, A. M., Lanooij, S. J. & de Melker, H. E. The National Immunisation Programme in the Netherlands. Surveillance and developments in 2023\u20132024. RIVM Report 2024-0072 https:\/\/doi.org\/10.21945\/RIVM-2024-0072 (2024).","DOI":"10.21945\/RIVM-2024-0072"},{"key":"69885_CR3","unstructured":"European Centre for Disease Prevention and Control. Increase of pertussis cases in the EU\/EEA. [Available from: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/increase-pertussis-cases-eueea (2024)."},{"key":"69885_CR4","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1586\/14760584.2014.935766","volume":"13","author":"JD Cherry","year":"2014","unstructured":"Cherry, J. D. & Paddock, C. D. Pathogenesis and histopathology of pertussis: implications for immunization. Expert Rev. Vaccines 13, 1115\u20131123 (2014).","journal-title":"Expert Rev. Vaccines"},{"key":"69885_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/cid\/ciz531","volume":"70","author":"R Craig","year":"2020","unstructured":"Craig, R. et al. Asymptomatic infection and transmission of pertussis in households: a systematic review. Clin. Infect. Dis. 70, 152\u2013161 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"69885_CR6","doi-asserted-by":"publisher","unstructured":"Schurink-van \u2018t Klooster, T. & de Melker, H. The National Immunisation Programme in the Netherlands: Surveillance and developments in 2019-2020. RIVM Report 2020-0077 https:\/\/doi.org\/10.21945\/RIVM-2020-0077 (2020).","DOI":"10.21945\/RIVM-2020-0077"},{"key":"69885_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100196","volume":"10","author":"P Versteegen","year":"2021","unstructured":"Versteegen, P. et al. More than 10 years after introduction of an acellular pertussis vaccine in infancy: a cross-sectional serosurvey of pertussis in the Netherlands. Lancet Reg. Health Eur. 10, 100196 (2021).","journal-title":"Lancet Reg. Health Eur."},{"key":"69885_CR8","doi-asserted-by":"publisher","unstructured":"van Lier, E. A. et al. Vaccinatiegraad Rijksvaccinatieprogramma Nederland Verslagjaar 2025. RIVM Report 2025-0019 https:\/\/doi.org\/10.21945\/RIVM-2025-0019 (2025).","DOI":"10.21945\/RIVM-2025-0019"},{"key":"69885_CR9","unstructured":"World Health Organization. Diphtheria, tetanus toxoid and pertussis (DTP) vaccination coverage\u2014Netherlands 2025 [Available from: https:\/\/immunizationdata.who.int\/global\/wiise-detail-page\/diphtheria-tetanus-toxoid-and-pertussis-(dtp)-vaccination-coverage? (2025)."},{"key":"69885_CR10","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1093\/cid\/cis287","volume":"54","author":"MA Witt","year":"2012","unstructured":"Witt, M. A., Katz, P. H. & Witt, D. J. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin. Infect. Dis. 54, 1730\u20131735 (2012).","journal-title":"Clin. Infect. Dis."},{"key":"69885_CR11","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1016\/j.vaccine.2018.03.029","volume":"36","author":"V Pool","year":"2018","unstructured":"Pool, V., Tomovici, A., Johnson, D. R., Greenberg, D. P. & Decker, M. D. Humoral immunity 10years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine in the USA. Vaccine 36, 2282\u20132287 (2018).","journal-title":"Vaccine"},{"key":"69885_CR12","doi-asserted-by":"publisher","first-page":"6956","DOI":"10.1016\/j.vaccine.2022.10.020","volume":"40","author":"H He","year":"2022","unstructured":"He, H. et al. The decline in immunity and circulation of pertussis among Chinese population during the COVID-19 pandemic: a cross-sectional sero-epidemiological study. Vaccine 40, 6956\u20136962 (2022).","journal-title":"Vaccine"},{"key":"69885_CR13","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.1016\/j.vaccine.2022.04.086","volume":"40","author":"F Reicherz","year":"2022","unstructured":"Reicherz, F., Golding, L., Lavoie, P. M. & Abu-Raya, B. Decay of anti-Bordetella pertussis antibodies in women of childbearing age following COVID-19 non-pharmaceutical measures. Vaccine 40, 3746\u20133751 (2022).","journal-title":"Vaccine"},{"key":"69885_CR14","doi-asserted-by":"crossref","unstructured":"Chen, Z. et al. Seroprevalence of pertussis in adults at childbearing age pre- and post-COVID-19 in Beijing, China. Vaccines 10, 872 (2022).","DOI":"10.3390\/vaccines10060872"},{"key":"69885_CR15","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1093\/infdis\/170.3.705","volume":"170","author":"Q He","year":"1994","unstructured":"He, Q. et al. Antibodies to filamentous hemagglutinin of Bordetella pertussis and protection against whooping cough in schoolchildren. J. Infect. Dis. 170, 705\u2013708 (1994).","journal-title":"J. Infect. Dis."},{"key":"69885_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1128\/iai.58.1.7-16.1990","volume":"58","author":"A Kimura","year":"1990","unstructured":"Kimura, A., Mountzouros, K. T., Relman, D. A., Falkow, S. & Cowell, J. L. Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model. Infect. Immun. 58, 7\u201316 (1990).","journal-title":"Infect. Immun."},{"key":"69885_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.605273","volume":"11","author":"I Yougbare","year":"2020","unstructured":"Yougbare, I. et al. Anti-FIM and anti-FHA antibodies inhibit Bordetella pertussis growth and reduce epithelial cell inflammation through bacterial aggregation. Front. Immunol. 11, 605273 (2020).","journal-title":"Front. Immunol."},{"key":"69885_CR18","doi-asserted-by":"publisher","first-page":"e0237394","DOI":"10.1371\/journal.pone.0237394","volume":"15","author":"A Zeddeman","year":"2020","unstructured":"Zeddeman, A. et al. Effect of FHA and Prn on Bordetella pertussis colonization of mice is dependent on vaccine type and anatomical site. PLoS ONE 15, e0237394 (2020).","journal-title":"PLoS ONE"},{"key":"69885_CR19","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/S0264-410X(98)00226-6","volume":"16","author":"JD Cherry","year":"1998","unstructured":"Cherry, J. D., Gornbein, J., Heininger, U. & Stehr, K. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 16, 1901\u20131906 (1998).","journal-title":"Vaccine"},{"key":"69885_CR20","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/S0264-410X(98)00227-8","volume":"16","author":"J Storsaeter","year":"1998","unstructured":"Storsaeter, J., Hallander, H. O., Gustafsson, L. & Olin, P. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 16, 1907\u20131916 (1998).","journal-title":"Vaccine"},{"key":"69885_CR21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S1201-9712(99)90035-8","volume":"3","author":"E Bergfors","year":"1999","unstructured":"Bergfors, E. et al. Parapertussis and pertussis: differences and similarities in incidence, clinical course, and antibody responses. Int. J. Infect. Dis. 3, 140\u2013146 (1999).","journal-title":"Int. J. Infect. Dis."},{"key":"69885_CR22","doi-asserted-by":"crossref","unstructured":"Poltorak, V. et al. Increase of pertussis cases in the vall\u00e8s region, Catalonia, Spain, September 2023 to April 2024. Eurosurveillance 29, 2400332 (2024).","DOI":"10.2807\/1560-7917.ES.2024.29.24.2400332"},{"key":"69885_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-5-40","volume":"5","author":"I Narkeviciute","year":"2005","unstructured":"Narkeviciute, I., Kavaliunaite, E., Bernatoniene, G. & Eidukevicius, R. Clinical presentation of pertussis in fully immunized children in Lithuania. BMC Infect. Dis. 5, 40 (2005).","journal-title":"BMC Infect. Dis."},{"key":"69885_CR24","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3201\/eid2902.221125","volume":"29","author":"F Moosa","year":"2023","unstructured":"Moosa, F. et al. Incidence and transmission dynamics of Bordetella pertussis infection in rural and urban communities, South Africa, 2016\u20122018. Emerg. Infect. Dis. 29, 294\u2013303 (2023).","journal-title":"Emerg. Infect. Dis."},{"key":"69885_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.05.052","volume":"42","author":"F Reicherz","year":"2024","unstructured":"Reicherz, F. et al. Bordetella pertussis infection following relaxation of COVID-19 non-pharmaceutical interventions in 2021\u20132023 in Vancouver metropolitan area, British Columbia, Canada. Vaccine 42, 126004 (2024).","journal-title":"Vaccine"},{"key":"69885_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0382-8","volume":"13","author":"BM Althouse","year":"2015","unstructured":"Althouse, B. M. & Scarpino, S. V. Asymptomatic transmission and the resurgence of Bordetella pertussis. BMC Med. 13, 146 (2015).","journal-title":"BMC Med."},{"key":"69885_CR27","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1073\/pnas.1314688110","volume":"111","author":"JM Warfel","year":"2014","unstructured":"Warfel, J. M., Zimmerman, L. I. & Merkel, T. J. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc. Natl. Acad. Sci. USA. 111, 787\u2013792 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"69885_CR28","doi-asserted-by":"crossref","unstructured":"Versteegen, P. et al. Long-term immunogenicity upon pertussis booster vaccination in young adults and children in relation to priming vaccinations in infancy. Vaccines 10, 693 (2022).","DOI":"10.3390\/vaccines10050693"},{"key":"69885_CR29","doi-asserted-by":"crossref","unstructured":"Lambert, E. E. et al. Uncovering distinct primary vaccination-dependent profiles in human Bordetella pertussis specific CD4+ T-cell responses using a novel whole blood assay. Vaccines 8, 225 (2020).","DOI":"10.3390\/vaccines8020225"},{"key":"69885_CR30","doi-asserted-by":"crossref","unstructured":"da Silva, A. R. et al. T cell reactivity to Bordetella pertussis is highly diverse regardless of childhood vaccination. Cell Host Microbe. 31, 1404\u20131416.e4 (2023).","DOI":"10.1016\/j.chom.2023.06.015"},{"key":"69885_CR31","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.vaccine.2017.11.066","volume":"36","author":"S van der Lee","year":"2018","unstructured":"van der Lee, S., Sanders, E. A. M., Berbers, G. A. M. & Buisman, A. M. Whole-cell or acellular pertussis vaccination in infancy determines IgG subclass profiles to DTaP booster vaccination. Vaccine 36, 220\u2013226 (2018).","journal-title":"Vaccine"},{"key":"69885_CR32","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1016\/S0264-410X(02)00823-X","volume":"21","author":"A Giammanco","year":"2003","unstructured":"Giammanco, A. et al. Analogous IgG subclass response to pertussis toxin in vaccinated children, healthy or affected by whooping cough. Vaccine 21, 1924\u20131931 (2003).","journal-title":"Vaccine"},{"key":"69885_CR33","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.jaci.2009.09.046","volume":"125","author":"HW Schroeder Jr.","year":"2010","unstructured":"Schroeder, H. W. Jr. & Cavacini, L. Structure and function of immunoglobulins. J. Allergy Clin. Immunol. 125, S41\u2013S52 (2010).","journal-title":"J. Allergy Clin. Immunol."},{"key":"69885_CR34","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1080\/21505594.2021.1980987","volume":"12","author":"T Belcher","year":"2021","unstructured":"Belcher, T., Dubois, V., Rivera-Millot, A., Locht, C. & Jacob-Dubuisson, F. Pathogenicity and virulence of Bordetella pertussis and its adaptation to its strictly human host. Virulence 12, 2608\u20132632 (2021).","journal-title":"Virulence"},{"key":"69885_CR35","doi-asserted-by":"crossref","unstructured":"Barkoff, A. M. et al. Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015. Eurosurveillance 24, 1700832 (2019).","DOI":"10.2807\/1560-7917.ES.2019.24.7.1700832"},{"key":"69885_CR36","doi-asserted-by":"publisher","unstructured":"Visser, L. J. et al. Resurgence of Bordetella pertussis in the Netherlands in 2023-2024 reveals novel mutation in T3SS translocator gene bopD. Preprint at https:\/\/doi.org\/10.1101\/2025.09.05.25335159 (2025).","DOI":"10.1101\/2025.09.05.25335159"},{"key":"69885_CR37","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1136\/jech-2020-215678","volume":"75","author":"ERA Vos","year":"2020","unstructured":"Vos, E. R. A. et al. Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave. J. Epidemiol. Community Health 75, 489\u2013495 (2020).","journal-title":"J. Epidemiol. Community Health"},{"key":"69885_CR38","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.1093\/cid\/ciw550","volume":"63","author":"JD Cherry","year":"2016","unstructured":"Cherry, J. D. Pertussis in young infants throughout the world. Clin. Infect. Dis. 63, S119\u2013s22 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"69885_CR39","unstructured":"RIVM. Current figures on whooping cough in the Netherlands. [Available from: https:\/\/www.rivm.nl\/en\/whooping-cough\/current-figures-on-whooping-cough-in-netherlands (2025)."},{"key":"69885_CR40","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1093\/cid\/ciab264","volume":"73","author":"ERA Vos","year":"2021","unstructured":"Vos, E. R. A. et al. Associations between measures of social distancing and severe acute respiratory syndrome coronavirus 2 seropositivity: a nationwide population-based study in the Netherlands. Clin. Infect. Dis. 73, 2318\u20132321 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"69885_CR41","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13312","volume":"18","author":"EricRA Vos","year":"2024","unstructured":"Vos, E. ricR. A. et al. SARS-CoV-2 seroprevalence trends in the Netherlands in the variant of concern era: input for future response. Influenza Other Respir. Viruses 18, e13312 (2024).","journal-title":"Influenza Other Respir. Viruses"},{"key":"69885_CR42","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1128\/CVI.05537-11","volume":"19","author":"GP Smits","year":"2012","unstructured":"Smits, G. P., van Gageldonk, P. G., Schouls, L. M., van der Klis, F. R. & Berbers, G. A. Development of a bead-based multiplex immunoassay for simultaneous quantitative detection of IgG serum antibodies against measles, mumps, rubella, and varicella-zoster virus. Clin. Vaccin. Immunol. 19, 396\u2013400 (2012).","journal-title":"Clin. Vaccin. Immunol."},{"key":"69885_CR43","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jim.2008.02.018","volume":"335","author":"PG van Gageldonk","year":"2008","unstructured":"van Gageldonk, P. G., van Schaijk, F. G., van der Klis, F. R. & Berbers, G. A. Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus. J. Immunol. Methods 335, 79\u201389 (2008).","journal-title":"J. Immunol. Methods"},{"key":"69885_CR44","unstructured":"Mollers, M. & Ruijs, W. L. M. Kinkhoest Richtlijn. Available from: https:\/\/lci.rivm.nl\/richtlijnen\/kinkhoest"},{"key":"69885_CR45","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1128\/CVI.00229-12","volume":"19","author":"SC de Greeff","year":"2012","unstructured":"de Greeff, S. C. et al. Two-component cluster analysis of a large serodiagnostic database for specificity of increases of IgG antibodies against pertussis toxin in paired serum samples and of absolute values in single serum samples. Clin. Vaccin. Immunol. 19, 1452\u20131456 (2012).","journal-title":"Clin. Vaccin. Immunol."},{"key":"69885_CR46","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s10096-010-1104-y","volume":"30","author":"N Guiso","year":"2011","unstructured":"Guiso, N. et al. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur. J. Clin. Microbiol. Infect. Dis. 30, 307\u2013312 (2011).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"69885_CR47","doi-asserted-by":"publisher","first-page":"3732","DOI":"10.1016\/j.vaccine.2013.05.073","volume":"31","author":"GAM Berbers","year":"2013","unstructured":"Berbers, G. A. M. et al. A novel method for evaluating natural and vaccine induced serological responses to Bordetella pertussis antigens. Vaccine 31, 3732\u20133738 (2013).","journal-title":"Vaccine"},{"key":"69885_CR48","doi-asserted-by":"publisher","first-page":"e14183","DOI":"10.1371\/journal.pone.0014183","volume":"5","author":"SC de Greeff","year":"2010","unstructured":"de Greeff, S. C. et al. Seroprevalence of pertussis in the Netherlands: evidence for increased circulation of Bordetella pertussis. PLoS ONE 5, e14183 (2010).","journal-title":"PLoS ONE"},{"key":"69885_CR49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ijid.2021.08.025","volume":"111","author":"MM Immink","year":"2021","unstructured":"Immink, M. M. et al. Circulation of Bordetella pertussis in the Caribbean Netherlands: a population-based seroepidemiological study. Int. J. Infect. Dis. 111, 21\u201327 (2021).","journal-title":"Int. J. Infect. Dis."},{"key":"69885_CR50","first-page":"1","volume":"3","author":"J Pinheiro","year":"2013","unstructured":"Pinheiro, J., Bates, D., DebRoy, S. S. & Sarkar, D. Nlme: linear and nonlinear mixed effects models. R. Package Version 31-110 3, 1\u2013113 (2013).","journal-title":"R. Package Version 31-110"},{"key":"69885_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v042.i08","volume":"42","author":"D Ho","year":"2011","unstructured":"Ho, D., Imai, K., King, G. & Stuart, E. A. MatchIt: nonparametric preprocessing for parametric causal inference. J. Stat. Softw. 42, 1\u201328 (2011).","journal-title":"J. Stat. Softw."},{"key":"69885_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v087.i09","volume":"87","author":"J Fox","year":"2018","unstructured":"Fox, J. & Weisberg, S. Visualizing fit and lack of fit in complex regression models with predictor effect plots and partial residuals. J. Stat. Softw. 87, 1\u201327 (2018).","journal-title":"J. Stat. Softw."},{"key":"69885_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin, X. et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 12, 77 (2011).","journal-title":"BMC Bioinform."},{"key":"69885_CR54","unstructured":"Mathieu, E. et al. Coronavirus Pandemic (COVID-19). Our World In Data. Available from: https:\/\/ourworldindata.org\/coronavirus (2020)."},{"key":"69885_CR55","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41562-021-01079-8","volume":"5","author":"T Hale","year":"2021","unstructured":"Hale, T. et al. A global panel database of pandemic policies (Oxford COVID-19 government response tracker). Nat. Hum. Behav. 5, 529\u2013538 (2021).","journal-title":"Nat. Hum. Behav."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69885-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69885-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69885-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T12:56:14Z","timestamp":1774875374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69885-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["69885"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-69885-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2989"}}